LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, will showcase its regional anesthesia and pain management products featuring improved practices during the ESRA Congress in Glasgow, UK, on September 4-7, 2013.
At the ESRA, September 4-7, Teleflex will highlight its diversified range of regional anesthesia and pain management products. The Company will place particular attention upon its newly designed FlexBlockTM catheterization sets, UltraQuikTM peripheral nerve block needles and the ambIT® PCA pump.
The FlexBlockTM catheterization sets provide clinicians with an echogenic stimulating / non-stimulating needle and the option of ultrasound techniques. The FlexBlock catheter’s unique design offers a combination of ultrasound visibility, flexibility, excellent kink-resistance and a catheter tip that is designed to provide a predictable spread of anesthetic.
Arrow brand clinician inspired UltraQuik peripheral nerve block needles are designed to help increase overall block success when performing single-shot peripheral nerve blocks using ultrasound. To make it as straightforward as possible to identify the needle under ultrasound, the distal end of the needle cannula has five grooved rings.
The ambIT PCA pump ambulatory pain control systems for post-operative pain management from Summit provide flexible, accurate and safe therapy-specific configurations at the lowest cost-in use.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care, urology and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Limerick, PA, Teleflex employs approximately 11,500 people worldwide and serves healthcare providers in more than 140 countries. Additional information about Teleflex can be obtained from the company's website at teleflex.com.
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.
FlexBlock and UltraQuik are trademarks or registered trademarks of Teleflex Incorporated or its affiliates. ©2013 Teleflex Incorporated. All rights reserved.
ambIT® is a trademark of Summit Medical Products, Inc. All rights reserved.